MedAvante provide services to pharmaceutical companies for the planning, execution and management of clinical trials specifically in the development of drugs for central nervous system disorders such as Alzheimer's and Parkinson's. I worked with a talented team at Method to develop a new brand and product strategy then I led the design of a new brand identity and UI system which leveraged big data and intelligent insights to provide value in a highly complex, competitive and dynamic market.
The parent and product brands co-exist as a coherent system attuned to discrete user segments: MedAvante has a cool objectivity and more complex form for buyers, Virgil is simpler and more intimate aimed at users.